Healthcare resource utilization and costs of letermovir for cytomegalovirus-prophylaxis after allogeneic hematopoietic cell transplantation in a real-world, multi-centre study in Germany.

Saved in:
Bibliographic Details
Title: Healthcare resource utilization and costs of letermovir for cytomegalovirus-prophylaxis after allogeneic hematopoietic cell transplantation in a real-world, multi-centre study in Germany.
Authors: Engelhard M; Faculty of Medicine, Department I of Internal Medicine, University of Cologne, University Hospital Cologne, Cologne, Germany.; Faculty of Medicine, Goethe University Frankfurt, Institute for Digital Medicine and Clinical Data Science, Frankfurt am Main, Germany., Wingen-Heimann SM; Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany.; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Faculty of Medicine), University Hospital Cologne, University of Cologne, Cologne, Germany.; University of Applied Sciences for Economics and Management (FOM), Cologne, Germany.; German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany., Classen AY; Faculty of Medicine, Department I of Internal Medicine, University of Cologne, University Hospital Cologne, Cologne, Germany.; German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany., Blau IW; Department of Hematology, Oncology and Tumorimmunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Augustenburger Platz 1, 13353, Berlin, Germany., Bug G; Department of Medicine 2, Goethe University Frankfurt, University Hospital, Frankfurt am Main, Germany., Hebermehl C; Department of Hematology and Medical Oncology, University Medical Centre of the Johannes Gutenberg University Mainz, Mainz, Germany., Kraus S; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany., Penack O; Department of Hematology, Oncology and Tumorimmunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany., Rettig AR; Department of Medicine I/Hematology, Oncology and Stem Cell Transplantation, Medical Centre, Faculty of Medicine, University of Freiburg, University of Freiburg, Freiburg, Germany., Schmitt T; Department of Hematology and Medical Oncology, University Medical Centre of the Johannes Gutenberg University Mainz, Mainz, Germany., Steinbrunn T; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Teschner D; Department of Hematology and Medical Oncology, University Medical Centre of the Johannes Gutenberg University Mainz, Mainz, Germany.; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany., Vehreschild MJGT; Department of Internal Medicine, Infectious Diseases, Goethe University Frankfurt, University Hospital Frankfurt, Frankfurt am Main, Germany., Wehr C; Department of Medicine I/Hematology, Oncology and Stem Cell Transplantation, Medical Centre, Faculty of Medicine, University of Freiburg, University of Freiburg, Freiburg, Germany., Vehreschild JJ; Faculty of Medicine, Department I of Internal Medicine, University of Cologne, University Hospital Cologne, Cologne, Germany.; German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.; Faculty of Medicine, Goethe University Frankfurt, Institute for Digital Medicine and Clinical Data Science, Frankfurt am Main, Germany., Pütz SM; Department I of Internal Medicine, Division of Infectious Diseases, University Hospital Cologne, Kerpener Straße 62, 50937, Cologne, Germany. sina.puetz@uk-koeln.de.
Source: The European journal of health economics : HEPAC : health economics in prevention and care [Eur J Health Econ] 2026 Feb 16. Date of Electronic Publication: 2026 Feb 16.
Publication Type: Journal Article
Journal Info: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 101134867 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1618-7601 (Electronic) Linking ISSN: 16187598 NLM ISO Abbreviation: Eur J Health Econ Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1618-7601
DOI:10.1007/s10198-025-01890-4